3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
2
Sarcoma
1
Other hematologic neoplasm
1
Gastrointestinal
1
Classical hematology
1
Conditions
Sarcoma
266
Osteosarcoma
81
Sarcoma, Ewing
51
Melanoma
44
Neoplasms
43
Gastrointestinal Stromal Tumors
41
Colorectal Neoplasms
39
Breast Neoplasms
38
Rhabdomyosarcoma
36
Bone Neoplasms
36
Ovarian Neoplasms
32
Neoplasm Metastasis
32
Neuroblastoma
30
Pancreatic Neoplasms
29
Stomach Neoplasms
27
Dendritic Cell Sarcoma, Interdigitating
27
Lung Neoplasms
26
Liposarcoma
26
Leiomyosarcoma
26
Glioblastoma
23
Uterine Cervical Neoplasms
22
Sarcoma, Synovial
22
Head and Neck Neoplasms
22
Carcinoma, Non-Small-Cell Lung
22
Esophageal Neoplasms
21
Lymphoma
19
Sarcoma, Kaposi
18
Prostatic Neoplasms
18
Carcinoma, Hepatocellular
18
Urinary Bladder Neoplasms
17
Interventions
Immune Checkpoint Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Adenoviridae Infections
×
Sarcoma
×
Clear all
NCT04673942
2024-10-26
BETA-PRIME
EpicentRx, Inc.
Phase 2
Recruiting
140 enrolled